Amarin’s Vascepa: US FDA Panel To Scrutinize Breadth Of CV Risk Reduction

 
• By Sue Sutter
PS1911_Big-game-fishing_223578337_1200.jpg
Amarin is hoping to finally reel in the big indication for its fish oil-derived drug Vascepa. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers